Medicamen Biotech's consolidated quarterly results show a 2.76% increase in net sales to Rs 44.74 crore in September 2024, while quarterly net profit decreased by 1.37% to Rs 1.46 crore. EBITDA rose 8.09% to Rs 5.61 crore, and shares closed at 442.65 on November 26, 2024, with -15.47% returns over 6 months and -30.40% over 12 months.
Open FlipReported Consolidated quarterly numbers for Tolins Tyres are: Net Sales at Rs 76.88 crore in September 2024 up 64.24% from Rs. 46.81 crore in September 2023. Quarterly Net Profit at Rs. 9.60 crore in September 2024 up 13.46% from Rs. 8.46 crore in September 2023. EBITDA stands at Rs. 15.35 crore in September 2024 up 16.2% from Rs. 13.21 crore in September 2023.
Open FlipReported Consolidated quarterly numbers for Banco Products (India) are: Net Sales at Rs 894.93 crore in September 2024 up 23.51% from Rs. 724.56 crore in September 2023. Quarterly Net Profit at Rs. 138.70 crore in September 2024 up 109.8% from Rs. 66.11 crore in September 2023. EBITDA stands at Rs. 222.58 crore in September 2024 up 77.3% from Rs. 125.54 crore in September 2023.
Open Flip